Stocks · Healthcare · Medical - Devices
Align Technology, Inc. ALGN
$143.74 -1.11% Close, Oct 2, 2026 · NASDAQ · Market cap $10.29B
High qualityInexpensive vs sector
Next earnings report: Oct 28, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The shares trade at 25.0× trailing earnings, lower than 95% of the company's own readings over the past five years.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
- Earnings beat analyst estimates in each of the last 4 quarters (average surprise over the last four: +7.9%).
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 39%
- EPS growth (TTM, YoY)Bottom 42%
- FCF growth (TTM, YoY)Top 47%
- Revenue growth, 3-year CAGRBottom 31%
- Revenue growth accelerationTop 32%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 17%
- Gross marginTop 48%
- Operating marginTop 19%
- Cash conversion (OCF / net income)Top 36%
- Accruals (lower is better)Bottom 44%
- Net debt / EBITDA (lower is better)Top 17%
- Interest coverTop 2%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 14%
- Free-cash-flow yieldTop 12%
- EBITDA / enterprise valueTop 12%
- Sales / enterprise valueTop 28%
- P/E vs own 5-year history (lower is better)Top 15%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 47%
- 6-month returnBottom 27%
- 1-year return vs S&P 500Top 49%
- Distance from 52-week highTop 44%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 42%
- Consecutive EPS beatsTop 19%
- Share of analysts rating BuyBottom 42%
- Upside to consensus price targetBottom 42%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 13%
- Maximum drawdown, 3 yearsTop 38%
- Beta vs S&P 500 (lower is better)Bottom 38%
- Net debt / EBITDA (lower is better)Top 17%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 2.9% | 4.4% | ↑ |
| EPS growth (YoY) | 8.6% | -2.9% | ↓ |
| Gross margin | 69.8% | 66.5% | ↓ |
| Operating margin | 15.1% | 13.3% | ↓ |
| FCF margin | 17.1% | 18.3% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 4.4% | 2.9% | ↑ | Bottom 39% |
| EPS growth (TTM, YoY) | -2.9% | 8.6% | ↓ | Bottom 42% |
| Gross margin | 66.5% | 69.8% | ↓ | Top 48% |
| Operating margin | 13.3% | 15.1% | ↓ | Top 19% |
| Net margin | 10.0% | 11.0% | ↓ | — |
| Free-cash-flow margin | 18.3% | 17.1% | ↑ | — |
| Return on invested capital | 8.8% | — | Top 17% | |
| Revenue growth, 3-year CAGR | 2.6% | — | Bottom 31% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.83×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -5.3%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 4.5%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -4.8 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- -1.25×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 352.9×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 0.83%
- Shareholder yield
- 0.83%
- Share count change, 1 year
- -1.3%
- Share count change, 3-year CAGR
- -2.2%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 4
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +7.9%
- Average 2-day reaction, last 8
- +0.1%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $205.25
- Target vs current price
- +42.8%
- Analysts with a rating
- 33
- Share rating Buy or Strong Buy
- 73%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 29, 2026 | +0.8% | +2.6% | -1.3% | -9.1% | — |
| Apr 29, 2026 | +12.2% | +0.6% | -4.8% | -8.1% | -5.8% |
| Feb 4, 2026 | +10.0% | +2.7% | +25.0% | +16.0% | +12.1% |
| Oct 29, 2025 | +8.8% | -0.9% | +1.9% | +10.8% | +25.9% |
| Jul 30, 2025 | -3.1% | -1.1% | -32.1% | -31.1% | -34.1% |
| Apr 30, 2025 | +7.0% | -2.5% | -2.6% | +1.3% | +15.6% |
| Feb 5, 2025 | +0.4% | +0.7% | -2.0% | -18.9% | -17.7% |
| Oct 23, 2024 | +1.7% | -1.5% | +0.9% | +5.6% | +8.2% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 29, 2026 | $2.64 | $2.62 | +0.8% | $1.06B |
| Apr 29, 2026 | $2.58 | $2.30 | +12.2% | $1.04B |
| Feb 4, 2026 | $3.29 | $2.99 | +10.0% | $1.05B |
| Oct 29, 2025 | $2.61 | $2.40 | +8.8% | $995.7M |
| Jul 30, 2025 | $2.49 | $2.57 | -3.1% | $1.01B |
| Apr 30, 2025 | $2.13 | $1.99 | +7.0% | $979.3M |
| Feb 5, 2025 | $2.44 | $2.43 | +0.4% | $995.2M |
| Oct 23, 2024 | $2.35 | $2.31 | +1.7% | $977.9M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 25.0× | 36.3× | 5th | Top 14% |
| P/E (forward) | 12.7× | — | — | — |
| EV / EBITDA | 11.8× | — | — | Top 12% |
| EV / Sales | 2.25× | — | — | Top 28% |
| Free-cash-flow yield | 7.34% | — | — | Top 12% |
| Earnings yield | 4.01% | — | — | Top 14% |
P/E over the past five years
Range 23.1× – 88.8× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +12.7%
- Earnings per share growth (TTM)
- -2.9%
- Change in P/E multiple
- +31.4%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -6.7%
- 200-day average slope (20 days)
- -0.1%
- Distance from 50-day average
- -10.3%
- Distance from 200-day average
- -15.6%
- RSI (14)
- 36.8
- Relative volume
- 0.60×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 33.4%
- Volatility vs own 5-year history
- 13th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.32
- Correlation with S&P 500
- 0.47
- Current drawdown from 1-year high
- -27.2%
- Maximum drawdown, 3 years
- -62.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 8, 2021 | Sep 25, 2025 | -82.9% | 1016 days | Not yet recovered |
| Feb 5, 2021 | Mar 8, 2021 | -20.1% | 20 days | 35 days (Apr 27, 2021) |
| Apr 27, 2021 | May 12, 2021 | -11.8% | 11 days | 36 days (Jul 2, 2021) |
| Jan 8, 2021 | Jan 27, 2021 | -10.7% | 12 days | 6 days (Feb 4, 2021) |
| Nov 5, 2020 | Nov 19, 2020 | -10.3% | 10 days | 7 days (Dec 1, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $10.29B
- P/E (TTM)
- 25.0
- EPS, diluted (TTM)
- $5.76
- Revenue (TTM)
- $4.14B
- 52-week range
- $124.91 – $200.44
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $3.95B | $3.73B | $3.86B | $4.00B | $4.03B |
| Gross profit | $2.94B | $2.63B | $2.71B | $2.80B | $2.76B |
| Operating income | $976.4M | $642.6M | $643.3M | $607.6M | $616.2M |
| Net income | $772.0M | $361.6M | $445.1M | $421.4M | $410.4M |
| EPS (diluted) | $9.69 | $4.61 | $5.81 | $5.62 | $5.65 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $977.9M | $995.2M | $979.3M | $1.01B | $995.7M | $1.05B | $1.04B | $1.06B |
| Net income | $116.0M | $103.8M | $93.2M | $124.6M | $56.8M | $135.8M | $112.8M | $108.3M |
| EPS (diluted) | $1.55 | $1.39 | $1.27 | $1.72 | $0.78 | $1.89 | $1.57 | $1.52 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $1.17B | $568.7M | $785.8M | $738.2M | $593.2M |
| Capital expenditure | -$401.1M | -$291.9M | -$177.7M | -$115.6M | -$102.4M |
| Free cash flow | $771.4M | $276.8M | $608.1M | $622.7M | $490.8M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$349.4M | -$408.9M | -$565.8M | -$327.6M | -$444.2M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $1.10B
- Total assets
- $6.42B
- Total liabilities
- $2.19B
- Total debt
- $120.8M
- Net debt
- -$981.7M
- Shareholders’ equity
- $4.23B
As of Jun 30, 2026 (filed Aug 5, 2026).
Short interest
- Shares sold short
- 3,901,037
- Days to cover
- 4.89
- Change vs previous report
- +1.2%
FINRA short interest, settlement date Sep 15, 2026.